This statistic shows the chronic hepatitis B therapeutics sales in 2014 and 2024, by major market. Sales for chronic hepatitis B therapeutics in the U.S. market were some 773 million U.S. dollars in 2014.
Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Major pharma markets epidemiology of chronic hepatitis B 2014
- Basic Statistic Epidemiology of bipolar disorder in 8 major pharma markets 2014
- Premium Statistic Global hip and knee reconstruction market value 2015 vs 2022 by region
- Premium Statistic Forecast of global biosurgery market value 2015 and 2022 by region
- Basic Statistic Bipolar disorder pharma market share in 8 major markets for 2014 & 2024
- Premium Statistic Number of medical tourists from the Middle East in South Korea 2015, by country
- Premium Statistic Number of medical tourism patients in South Korea for cancer treatment 2009-2013
- Premium Statistic Global hip and knee reconstruction market share 2015 and 2022 by region
- Premium Statistic Number of nurses employed by the NHS in Italy 2012-2020
- Basic Statistic Mammographs in Finland 2010-2020
About the region
9
- Premium Statistic Pharmaceutical bipolar disorder drug sales 2014 by major market
- Premium Statistic Chronic hepatitis B therapeutic sales share among 8 major markets
- Premium Statistic Global body contouring market share 2015 & 2022 by country
- Premium Statistic Forecast of global point of care diagnostics market value 2015 and 2021 by region
- Premium Statistic Global point of care diagnostic market revenue 2015 and 2021 by country
- Basic Statistic Value of select contract pharma manufacturing companies 2022
- Basic Statistic Countries with highest government health expenditure share 2020
- Premium Statistic Percentage of births attended by skilled health personnel by world region 2013-2022
- Premium Statistic Global list of top health care equipment and service companies based on revenue 2023
Other regions
10
- Premium Statistic Expenditures on healthcare in the UAE 2011-2027
- Premium Statistic Share of fatalities in Qatar by major cause 2019
- Premium Statistic Expenditures on healthcare in Kuwait 2011-2027
- Premium Statistic Share of fatalities in Saudi Arabia 2019, by major cause
- Premium Statistic Share of fatalities in Bahrain by major cause 2019
- Premium Statistic Density rate of physicians in the GCC 2020, by country
- Premium Statistic Death rate for liver diseases & cirrhosis in Taiwan 2007-2018
- Basic Statistic Value of the South Korean blood pressure monitor market 2008-2022
- Basic Statistic Value of North American medical imaging information systems market 2008-2022
- Premium Statistic Value of North American mobility aids and transportation device market 2007-2021
Related statistics
10
- Premium Statistic Value of North American sterilization equipment market 2007-2021, by country
- Premium Statistic Physician spending as percent total health in each Canadian province 2023
- Basic Statistic Physician spending per capita in Canada by province 2023
- Basic Statistic Provincial/territorial government hospital expenditures in Canada by age 2021
- Premium Statistic Total Canadian other professional's health spending by type and source 2023
- Premium Statistic Hospital spending as share of total health spending in each Canadian province 2023
- Premium Statistic Hospital spending per capita in Canada by province 2023
- Basic Statistic Value of top home care or hospice providers in the U.S. 2021
- Basic Statistic Number of oncology specialty physicians in the U.S. 2016
- Premium Statistic Distribution of U.S. oncology practices by size and setting 2016
Further related statistics
9
- Medicaid long-term care services expenditures by type of service 1990-21
- Cost savings through urgent care vs emergency department 2012
- Net earnings of UnitedHealth Group 2007-2023
- Doctor visits in Germany - number per capita 1991-2021
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Leading causes of death among Black U.S. residents in 2020 and 2021
- Location of death among hospice patients in the U.S. 2018
- Presence of mental ill health in England 2014, by gender
- Size of U.S. hospices by number of admissions 2012-2014
Further Content: You might find this interesting as well
Statistics
- Medicaid long-term care services expenditures by type of service 1990-21
- Cost savings through urgent care vs emergency department 2012
- Net earnings of UnitedHealth Group 2007-2023
- Doctor visits in Germany - number per capita 1991-2021
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Leading causes of death among Black U.S. residents in 2020 and 2021
- Location of death among hospice patients in the U.S. 2018
- Presence of mental ill health in England 2014, by gender
- Size of U.S. hospices by number of admissions 2012-2014
GlobalData. (January 1, 2016). Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 25, 2024, from https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. "Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars)." Chart. January 1, 2016. Statista. Accessed May 25, 2024. https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. (2016). Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 25, 2024. https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. "Chronic Hepatitis B Therapeutics Sales in Selected Major Markets in 2014 and 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 1 Jan 2016, https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData, Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/ (last visited May 25, 2024)
Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) [Graph], GlobalData, January 1, 2016. [Online]. Available: https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/